A citation-based method for searching scientific literature

Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, Kris Jardon, Andrés Redondo, Richard G Moore, Christof Vulsteke, Roisin E O'Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley F Haggerty, Maria J Rubio-Pérez, Mark S Shahin, Giorgia Mangili, William H Bradley, Ilan Bruchim, Kaiming Sun, Izabela A Malinowska, Yong Li, Divya Gupta, Bradley J Monk. N Engl J Med 2019
Times Cited: 338



Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord, Kathy J Agnew, Colin C Pritchard, Sheena Scroggins, Rochelle L Garcia, Mary-Claire King, Elizabeth M Swisher. Clin Cancer Res 2014
Times Cited: 484




List of shared articles



Times cited


The current landscape of molecular profiling in the treatment of epithelial ovarian cancer.
Carolyn E Haunschild, Krishnansu S Tewari. Gynecol Oncol 2021
3

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease.
Rebecca C Arend, Amy Jackson-Fisher, Ira A Jacobs, Jeffrey Chou, Bradley J Monk. Cancer Biol Ther 2021
0


Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation.
Marjolijn M Ladan, Dik C van Gent, Agnes Jager. Cancers (Basel) 2021
0

The systemic treatment of recurrent ovarian cancer revisited.
T Baert, A Ferrero, J Sehouli, D M O'Donnell, A González-Martín, F Joly, J van der Velden, P Blecharz, D S P Tan, D Querleu,[...]. Ann Oncol 2021
2

Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know.
Luigi Della Corte, Virginia Foreste, Claudia Di Filippo, Pierluigi Giampaolino, Giuseppe Bifulco. Expert Opin Investig Drugs 2021
0

PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data.
Myrto Moutafi, Panagiota Economopoulou, David Rimm, Amanda Psyrri. Oral Oncol 2021
2

PARP inhibitors and immunotherapy in ovarian and endometrial cancers.
Rowan E Miller, Amy J Lewis, Melanie E Powell. Br J Radiol 2021
0